- Home
- VRME vs TENX Comparison
VRME vs TENX Comparison
Compare VRME & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRME
- TENX
- Stock Information
- Founded
- VRME 1999
- TENX 1967
- Country
- VRME United States
- TENX United States
- Employees
- VRME N/A
- TENX N/A
- Industry
- VRME EDP Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- VRME Technology
- TENX Health Care
- Exchange
- VRME Nasdaq
- TENX Nasdaq
- Market Cap
- VRME 14.5M
- TENX 11.4M
- IPO Year
- VRME N/A
- TENX N/A
- Fundamental
- Price
- VRME $1.32
- TENX $3.39
- Analyst Decision
- VRME Buy
- TENX Strong Buy
- Analyst Count
- VRME 1
- TENX 2
- Target Price
- VRME $1.50
- TENX $30.00
- AVG Volume (30 Days)
- VRME 15.0K
- TENX 29.1K
- Earning Date
- VRME 11-06-2024
- TENX 11-11-2024
- Dividend Yield
- VRME N/A
- TENX N/A
- EPS Growth
- VRME N/A
- TENX N/A
- EPS
- VRME N/A
- TENX N/A
- Revenue
- VRME $25,428,000.00
- TENX N/A
- Revenue This Year
- VRME $1.14
- TENX N/A
- Revenue Next Year
- VRME $10.56
- TENX N/A
- P/E Ratio
- VRME N/A
- TENX N/A
- Revenue Growth
- VRME N/A
- TENX N/A
- 52 Week Low
- VRME $0.85
- TENX $2.77
- 52 Week High
- VRME $2.45
- TENX $61.20
- Technical
- Relative Strength Index (RSI)
- VRME 48.69
- TENX 42.55
- Support Level
- VRME $1.28
- TENX $3.28
- Resistance Level
- VRME $1.43
- TENX $3.54
- Average True Range (ATR)
- VRME 0.11
- TENX 0.20
- MACD
- VRME -0.01
- TENX -0.01
- Stochastic Oscillator
- VRME 32.04
- TENX 26.42
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.